The Specialty Drug Problem
By the Numbers
291
291 of 533 new drugs expected to seek FDA approval by 2020 are specialty drugs.
$750k
Treatment regimens can be very costly, some reaching as much as $750,000/year.
21%
The average annual cost increase of Specialty Drugs is 21% based on a three year trend.
So, what's the solution?
Independent, Unbiased
Prior Authorization of Specialty Drugs
RxResults removes the
conflict of interest.
Our model is designed to make certain the right member meeting the right clinical criteria gets the right drug at the right time in an effort to achieve the best clinical outcome.

RxResults has a marked advantage due to their relationship with the nationally recognized University of Arkansas for Medical Sciences.
RxResults provides independent, non-biased clinical prior authorization review of specialty drugs. PBMs still provide pharmacy benefit management services & specialty pharmacy services, including fulfillment of specialty drugs.